These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11293687)

  • 21. Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh.
    Shirin T; Ahmed T; Iqbal A; Islam M; Islam MN
    J Health Popul Nutr; 2000 Dec; 18(3):145-50. PubMed ID: 11262767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alarming epidemics of human immunodeficiency virus and hepatitis C virus among injection drug users in the northwestern bordering state of Punjab, India: prevalence and correlates.
    Panda S; Roy T; Pahari S; Mehraa J; Sharma N; Singh G; Singh J; Joseph F; Singh S; Sharma NM
    Int J STD AIDS; 2014 Jul; 25(8):596-606. PubMed ID: 24352120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
    Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G
    J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for hepatitis C virus infection among injecting drug users in Sydney.
    van Beek I; Buckley R; Stewart M; MacDonald M; Kaldor J
    Genitourin Med; 1994 Oct; 70(5):321-4. PubMed ID: 8001943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey.
    Weild AR; Gill ON; Bennett D; Livingstone SJ; Parry JV; Curran L
    Commun Dis Public Health; 2000 Jun; 3(2):121-6. PubMed ID: 10902255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.
    Garfein RS; Vlahov D; Galai N; Doherty MC; Nelson KE
    Am J Public Health; 1996 May; 86(5):655-61. PubMed ID: 8629715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
    Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
    Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
    Miller ER; Hellard ME; Bowden S; Bharadwaj M; Aitken CK
    J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measures to reduce HIV infection have not been successful to reduce the prevalence of HCV in intravenous drug users.
    Hernandez-Aguado I; Ramos-Rincon JM; Aviñio MJ; Gonzalez-Aracil J; Pérez-Hoyos S; de la Hera MG;
    Eur J Epidemiol; 2001; 17(6):539-44. PubMed ID: 11949726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis virus infection and liver disease in injecting drug users who died suddenly.
    McCruden EA; Hillan KJ; McKay IC; Cassidy MT; Clark JC
    J Clin Pathol; 1996 Jul; 49(7):552-5. PubMed ID: 8813952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study.
    van Beek I; Dwyer R; Dore GJ; Luo K; Kaldor JM
    BMJ; 1998 Aug; 317(7156):433-7. PubMed ID: 9703523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran.
    Zamani S; Ichikawa S; Nassirimanesh B; Vazirian M; Ichikawa K; Gouya MM; Afshar P; Ono-Kihara M; Ravari SM; Kihara M
    Int J Drug Policy; 2007 Oct; 18(5):359-63. PubMed ID: 17854723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human T-lymphotropic virus types 1 and 2 are rare among intravenous drug users in Eastern Europe.
    Jõgeda EL; Avi R; Pauskar M; Kallas E; Karki T; Des Jarlais D; Uusküla A; Lutsar I; Huik K
    Infect Genet Evol; 2016 Sep; 43():83-5. PubMed ID: 27223634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study.
    Rhodes T; Platt L; Maximova S; Koshkina E; Latishevskaya N; Hickman M; Renton A; Bobrova N; McDonald T; Parry JV
    Addiction; 2006 Feb; 101(2):252-66. PubMed ID: 16445554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spread of bloodborne viruses among Australian prison entrants.
    Crofts N; Stewart T; Hearne P; Ping XY; Breshkin AM; Locarnini SA
    BMJ; 1995 Feb; 310(6975):285-8. PubMed ID: 7866168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S.
    White EF; Garfein RS; Brouwer KC; Lozada R; Ramos R; Firestone-Cruz M; Pérez SG; Magis-Rodríguez C; Conde-Glez CJ; Strathdee SA
    Salud Publica Mex; 2007; 49(3):165-72. PubMed ID: 17589770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A method to detect the incidence of hepatitis C infection among injecting drug users in Glasgow 1993-98.
    Roy KM; Goldberg D; Taylor A; Hutchinson S; MacDonald L; Wilson KS; Cameron SO
    J Infect; 2001 Oct; 43(3):200-5. PubMed ID: 11798260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate them.
    Roy KM; Hutchinson SJ; Wadd S; Taylor A; Cameron SO; Burns S; Molyneaux P; McIntyre PG; Goldberg DJ
    Epidemiol Infect; 2007 Apr; 135(3):433-42. PubMed ID: 16893486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Male IDUs who have sex with men in England, Wales and Northern Ireland: are they at greater risk of bloodborne virus infection and harm than those who only have sex with women?
    Marongiu A; Hope VD; Parry JV; Ncube F
    Sex Transm Infect; 2012 Oct; 88(6):456-61. PubMed ID: 22628667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C virus infection in a large cohort of homosexually active men: independent associations with HIV-1 infection and injecting drug use but not sexual behaviour.
    Bodsworth NJ; Cunningham P; Kaldor J; Donovan B
    Genitourin Med; 1996 Apr; 72(2):118-22. PubMed ID: 8698359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.